KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Accounts Payables (2020 - 2026)

Organon has reported Accounts Payables over the past 7 years, most recently at $983.0 million for Q1 2026.

  • For Q1 2026, Accounts Payables fell 2.29% year-over-year to $983.0 million; the TTM value through Mar 2026 reached $983.0 million, down 2.29%, while the annual FY2025 figure was $952.0 million, 17.43% down from the prior year.
  • Accounts Payables for Q1 2026 was $983.0 million at Organon, up from $952.0 million in the prior quarter.
  • Over five years, Accounts Payables peaked at $1.3 billion in Q4 2023 and troughed at $952.0 million in Q4 2025.
  • A 5-year average of $1.1 billion and a median of $1.1 billion in 2025 define the central range for Accounts Payables.
  • On a YoY basis, Accounts Payables climbed as much as 309.47% in 2022 and fell as far as 38.55% in 2022.
  • Year by year, Accounts Payables stood at $1.1 billion in 2022, then increased by 16.08% to $1.3 billion in 2023, then fell by 12.25% to $1.2 billion in 2024, then decreased by 17.43% to $952.0 million in 2025, then rose by 3.26% to $983.0 million in 2026.
  • Business Quant data shows Accounts Payables for OGN at $983.0 million in Q1 2026, $952.0 million in Q4 2025, and $1.1 billion in Q3 2025.